We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

ALIFAX DIAG/SRE

Develops automated diagnostic instruments for ESR testing and Bacterial Culture read more Featured Products: More products

Download Mobile App





Alifax Demonstrates Automated Solutions to Improve Performance in Laboratory Settings

By LabMedica International staff writers
Posted on 07 Feb 2024
Print article
Image: The I-dOne for fast ID showcased at Medlab Middle East 2024 (Photo courtesy of Alifax)
Image: The I-dOne for fast ID showcased at Medlab Middle East 2024 (Photo courtesy of Alifax)

At Medlab Middle East 2024, Alifax (Polverara, Italy) is showcasing its innovative solutions designed to enhance efficiency, accuracy, and reliability in laboratory settings.

Visitors to the Alifax booth can discover firsthand the company’s automated solutions: the new Test1 2.0 ESR system, I-dOne for fast ID, Molecular Mouse RT-PCR & Sepsis panel, fast phenotypic MDRO screening, and more, all engineered to deliver precise results that drive better patient outcomes. The Test1 2.0 ESR system is a new generation instrument from Alifax that is designed for ESR determination in less than 20 seconds. The new and updated Alifax analyzer allows testing of the ESR rate and overcomes the majority of the variables and limitations of the classical sedimentation method, thanks to the capillary photometry technology.

Alifax is also highlighting I-dOne which uses ATR-FTIR technology to identify the bacterial spectra, which can be considered as the molecular fingerprint of microorganisms. I-dOne analyzes the spectrum produced by the interaction between intact microbial cells and IR light through the vibrational state of their chemical bonds. Each species produces a unique fingerprint-like FTIR spectrum. Results are reported as Microorganism ID along with a relative score that represents the reliability of the identification to known vibrational profiles of species present in the reference database.

In addition, Alifax is showcasing the Molecular Mouse RT-PCR & Sepsis panel which provides qualitative and fast analysis of target molecules through real-time PCR and ready-to-use cartridges. The Molecular Mouse system is the world’s first handheld platform for the Real-Time PCR. It uses ready-to-use lab-on-chip cartridges, with all lyophilized reagents in each micro-well, making it possible to perform up to six simultaneous multiplex reactions. Alifax’s Sepsis panel is the largest panel, with 64 different targets, for the rapid detection of microorganisms of major clinical relevance and their antibiotic-resistance genes, starting from positive blood cultures.

Related Links:
Alifax

New
Platinum Member
Flu SARS-CoV-2 Combo Test
OSOM® Flu SARS-CoV-2 Combo Test
Magnetic Bead Separation Modules
MAG and HEATMAG
POCT Fluorescent Immunoassay Analyzer
FIA Go
Gold Member
ADAMTS-13 Protease Activity Test
ATS-13 Activity Assay

Print article
77 ELEKTRONIKA

Channels

Clinical Chemistry

view channel
Image: PhD student and first author Tarek Eissa has analyzed thousands of molecular fingerprints (Photo courtesy of Thorsten Naeser / MPQ / Attoworld)

Screening Tool Detects Multiple Health Conditions from Single Blood Drop

Infrared spectroscopy, a method using infrared light to study the molecular composition of substances, has been a foundational tool in chemistry for decades, functioning similarly to a molecular fingerprinting... Read more

Molecular Diagnostics

view channel
Image: Researchers have found the first evidence of testing for the alpha-synuclein protein in blood samples via seed amplification assay (Photo courtesy of Shutterstock)

Blood Test to Detect Alpha-Synuclein Protein Could Revolutionize Parkinson's Disease Diagnostics

Currently, Parkinson's disease (PD) is identified through clinical diagnosis, typically at a later stage in the disease's progression. There is a pressing need for an objective and quantifiable biomarker... Read more

Hematology

view channel
Image: The Truvian diagnostic platform combines clinical chemistry, immunoassay and hematology testing in a single run (Photo courtesy of Truvian Health)

Automated Benchtop System to Bring Blood Testing To Anyone, Anywhere

Almost all medical decisions are dependent upon laboratory test results, which are essential for disease prevention and the management of chronic illnesses. However, routine blood testing remains limited worldwide.... Read more

Immunology

view channel
Image: The blood test measures lymphocytes  to guide the use of multiple myeloma immunotherapy (Photo courtesy of 123RF)

Simple Blood Test Identifies Multiple Myeloma Patients Likely to Benefit from CAR-T Immunotherapy

Multiple myeloma, a type of blood cancer originating from plasma cells in the bone marrow, sees almost all patients experiencing a relapse at some stage. This means that the cancer returns even after initially... Read more

Microbiology

view channel
Image: Ultra-Rapid Antimicrobial Susceptibility Testing (uRAST) revolutionizing traditional antibiotic susceptibility testing (Photo courtesy of Seoul National University)

Ultra-Rapid Culture-Free Sepsis Test Reduces Testing Time from Days to Hours

Sepsis, a critical emergency condition, results from an overactive inflammatory response to pathogens like bacteria or fungi in the blood, leading to organ damage and the possibility of sudden death.... Read more

Pathology

view channel
Image: The AI model can distinguish different stages of DCIS from inexpensive and readily available breast tissue images (Photo courtesy of David A. Litman/Shutterstock)

AI Model Identifies Breast Tumor Stages Likely To Progress to Invasive Cancer

Ductal carcinoma in situ (DCIS) is a non-invasive type of tumor that can sometimes progress to a more lethal form of breast cancer and represents about 25% of all breast cancer cases. Between 30% and 50%... Read more

Industry

view channel
Image: Beckman Coulter will utilize the ALZpath pTau217 antibody to detect key biomarker for Alzheimer\'s disease on its DxI 9000 immunoassay analyzer (Photo courtesy of Beckman Coulter)

Beckman Coulter Licenses Alzpath's Proprietary P-tau 217 Antibody to Develop Alzheimer's Blood Test

Cognitive assessments have traditionally been the primary method for diagnosing Alzheimer’s disease, but this approach has its limitations as symptoms become apparent only after significant brain changes... Read more
MEDLAB 2024
Copyright © 2000-2024 Globetech Media. All rights reserved.